Fujifilm, a world famous company known for innovation in high-tech areas, has leveraged its imaging and information technology to further develop its medical and health business amid the fight against the novel coronavirus (COVID-19) pandemic.
Fujifilm will bring their self-developed smart manufacturing products to this year’s 22nd China High-tech Fair, which will be held in Shenzhen, Guangdong province in November.
The smart manufacturing products independently developed by Fujifilm can effectively assist medical staff in disease diagnosis, as well as provide strong support for the smart manufacturing and medical industries in China.
Fujifilm has been committed to providing assistance to patients during the entire nursing process from early diagnosis to the development of new regenerative therapies. The company has also developed artificial intelligence (AI) applications in the medical industry. The medical AI brand created by Fujifilm combines AI technology with traditional image processing technology to automatically recognize anatomical structures, support lesion detection and measurement, as well as generate diagnostic reports.
During the COVID-19 pandemic, Fujifilm accelerated the expansion of its health and medical field. In addition to conducting clinical trials on therapeutic candidate drugs developed by the company, as well as commissioning the production of therapeutic candidate drugs and candidate vaccines for partner companies, Fujifilm also provided indispensable basic materials for the development and production of vaccines and therapeutic drugs.
In addition, Fujifilm also supplies medical equipment for diagnosis, such as automatic gene analysis devices that can realize simple and rapid PCR detection, small and lightweight mobile X-ray imaging systems for pneumonia diagnosis, as well as portable ultrasound diagnostic systems.
In the future, Fujifilm will combine the company's core technologies with new technologies like AI and the Internet of Things (IoT) to provide more innovative products and solutions for the smart manufacturing and medical and health fields, as well as to continue to contribute to the fight against the COVID-19 epidemic.